C&SS News
Notice of Annual General Meetings 2010
Position Statement and Paper
Role of Self Monitoring of Blood Glucose: Recommendations from the Canadian Agency for Drugs and Technologies in Health (CADTH) and the Canadian Diabetes Association.
Canadian Diabetes Association Statement on Insulin Glargine and the Possible Link to Cancer
At this time, the Canadian Diabetes Association believes there is insufficient evidence to conclude that there is an increased risk of cancer with the use of insulin glargine. This issue requires more detailed analysis and further studies (including randomized, controlled studies).
